🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma

Qorannoo klinikaalii Lymphoma Ameerikaa Keessatti hirmaatuu

Qorannoo 142 Lymphoma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06563505

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04234048

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03258567

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01441089

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT02917083

Rutgers University Study of the Genetics of Blood Cancers

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 110 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07714044

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06343311

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 3 hanga 39 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05442515

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07192471

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07583810

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07014293

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT03418038

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT00006518

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07013435

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT03223610

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04094610

Epco, Zanu, Ritux for R/R FL or MZL

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06563596

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Namoota walitti qabaa jiraSadarkaa 1
24 Months – 18 Years · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06441331

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT04083495

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT02974647

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.